Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Geron/P&U collaboration on telomerase inhibitors

Dec. 31, 1996

FDA identifies issues to be addressed for AccuSite approval

Dec. 31, 1996

U.K. launch for aromatase inhibitor

Dec. 31, 1996

Natural antitumor/antifungal agent disclosed by Fujisawa

Dec. 31, 1996

Dolastatin 10 derivatives from Teikoku Hormone

Dec. 31, 1996

Andrx licenses chemoprotective agent to Asta

Dec. 30, 1996

Natural antineoplastic agents described by Fujisawa

Dec. 24, 1996

ALRT-1550 to enter clinical trials

Dec. 23, 1996

QLT signs European licensing agreement for photosensitizer

Dec. 23, 1996

LHRH antagonists under study at Takeda

Dec. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...